A novel treatment CRB091 effectively reduces cancer cell proliferation in triple-negative breast cancer (TNBC)

/PRNewswire/ -- CRB091, a novel drug candidate developed by Cancer Research and Biotechnology AG (CRB), has shown significant promise in reducing cancer cell...

Related Keywords

Switzerland ,United Kingdom ,Kari Sarvanto ,Sarah Haddad ,Cancer Research Biotechnology ,Biotechnology Ltd ,Cancer Research ,Cancer Research And Biotechnology Ltd ,